0 NASDAQ Companies - June 17, 2019PhaseBio Announces Positive Preliminary Results from Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor in Older and Elderly SubjectsRead More
0 NASDAQ Companies - June 17, 2019Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common StockRead More
0 NASDAQ Companies - June 17, 2019Rockwell Medical Announces Proposed Public Offering of Common StockRead More
0 NASDAQ Companies - June 17, 2019Kimball International Earns Designation as a Great Place to Work-Certified™ Company in 2019Read More
0 NASDAQ Companies - June 17, 2019NXP Announces the Pricing Terms of Cash Tender Offer for Any and All 4.125% Senior Notes Due 2020Read More
0 TSX Venture News - June 17, 2019BioSyent to Present at Raymond James Life Sciences and MedTech ConferenceRead More
0 TSX News - June 17, 2019Jeff Parr Announced Winner of CVCA’s 2019 Ted Anderson Community Leadership AwardRead More
